CorMedix (CRMD) Enterprise Value (2016 - 2025)
Historic Enterprise Value for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to -$56.6 million.
- CorMedix's Enterprise Value fell 2292.93% to -$56.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.6 million, marking a year-over-year decrease of 2292.93%. This contributed to the annual value of -$51.7 million for FY2024, which is N/A changed from last year.
- Per CorMedix's latest filing, its Enterprise Value stood at -$56.6 million for Q3 2025, which was down 2292.93% from -$190.7 million recorded in Q2 2025.
- In the past 5 years, CorMedix's Enterprise Value ranged from a high of -$45.6 million in Q2 2024 and a low of -$190.7 million during Q2 2025
- Moreover, its 5-year median value for Enterprise Value was -$60.3 million (2022), whereas its average is -$70.1 million.
- Per our database at Business Quant, CorMedix's Enterprise Value soared by 4684.0% in 2024 and then tumbled by 31813.33% in 2025.
- Quarter analysis of 5 years shows CorMedix's Enterprise Value stood at -$65.5 million in 2021, then grew by 10.19% to -$58.8 million in 2022, then crashed by 47.28% to -$86.6 million in 2023, then soared by 40.31% to -$51.7 million in 2024, then fell by 9.47% to -$56.6 million in 2025.
- Its Enterprise Value was -$56.6 million in Q3 2025, compared to -$190.7 million in Q2 2025 and -$77.5 million in Q1 2025.